Emblem of Bayer AG is pictured on the annual outcomes information convention of the German drugmaker in Leverkusen, Germany February 27, 2019. REUTERS/Wolfgang Rattay
FRANKFURT, June 18 (Reuters) – A U.S. jury discovered Bayer’s (BAYGn.DE) Roundup weedkiller didn’t trigger an Oregon man’s most cancers, the German agriculture and prescription drugs firm stated on Saturday, handing the agency its fourth consecutive trial victory over such claims.
The decision, reached on Friday by the Circuit Courtroom of Jackson County, Oregon, is “in line with the assessments of skilled regulators worldwide in addition to the overwhelming proof from 4 many years of scientific research concluding that Roundup can be utilized safely and isn’t carcinogenic”, Bayer stated.
“We proceed to face behind the security of Roundup and can confidently defend the security of our product in addition to our good religion actions in any future litigation.”
Glyphosate is the lively ingredient in Bayer manufacturers akin to Roundup and RangerPro. It has been on the centre of mass litigation in the US introduced principally by residential gardeners claiming the weedkiller induced their most cancers.
The corporate has spent billions of {dollars} to settle near 100,000 Roundup circumstances.
Reporting by Christoph Steitz
Modifying by Mark Potter
: .
